FDA Approves First SGLT2 Inhibitor for Use in Children With Type 2 Diabetes

Jardiance and Synjardy approved as an addition to diet and exercise to improve blood sugar control in children aged 10 years and older with type 2 diabetes.

Related Keywords

Michelle Carey ,Boehringer Ingelheim ,Division Of Diabetes ,Lipid Disorders ,Drug Evaluation ,